Calmodulin binds to the cytoplasmic domain of angiotensin-converting enzyme and regulates its phosphorylation and cleavage secretion

被引:22
作者
Chattopadhyay, S
Santhamma, KR
Sengupta, S
McCue, B
Kinter, M
Sen, GC
Sen, I
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA
关键词
D O I
10.1074/jbc.M501718200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rate of cleavage secretion of the enzymatically active ectodomain of angiotensin-converting enzyme ( ACE) is regulated by tyrosine phosphorylation of the protein and by the phorbol ester, phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C. Here, we report that both calmodulin inhibitor (CaMI) and calmodulin kinase inhibitor could also enhance cleavage secretion of ACE. This effect was accompanied by the dissociation of calmodulin from a specific region within the cytoplasmic domain of ACE to which it had been bound. The same domain of ACE was phosphorylated, and both CaMI and PMA caused dephosphorylation of ACE as well. Mass spectrometric and mutational analyses identified Ser(730) as the only phosphorylated residue in the cytoplasmic domain of ACE. The Ser(730) --> Ala mutant of ACE was not phosphorylated, but it still bound calmodulin, and its cleavage secretion was enhanced by both CaMI and PMA. Similarly, when Ser(730) was replaced by the phosphoserine mimetic, Asp, cleavage secretion of the resultant mutant remained susceptible to the enhancing effect of CaMI and PMA. These results demonstrate that, although CaMI and PMA can enhance both cleavage secretion of ACE and its dephosphorylation, the two effects are not mutually interdependent.
引用
收藏
页码:33847 / 33855
页数:9
相关论文
共 44 条
[1]   The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein [J].
Allinson, TMJ ;
Parkin, ET ;
Condon, TP ;
Schwager, SLU ;
Sturrock, ED ;
Turner, AJ ;
Hooper, NM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (12) :2539-2547
[2]   Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells [J].
Annabi, B ;
Pilorget, A ;
Bousquet-Gagnon, N ;
Gingras, D ;
Béliveau, R .
BIOCHEMICAL JOURNAL, 2001, 359 (02) :325-333
[3]   Shedding of plasma membrane proteins [J].
Arribas, J ;
Merlos-Suárez, A .
CELL SURFACE PROTEASES, 2003, 54 :125-144
[4]   Protein ectodomain shedding [J].
Arribas, J ;
Borroto, A .
CHEMICAL REVIEWS, 2002, 102 (12) :4627-4637
[5]   Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? [J].
Bauvois, B .
ONCOGENE, 2004, 23 (02) :317-329
[6]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[7]   Remarkable roles of proteolysis on and beyond the cell surface [J].
Blobel, CP .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (05) :606-612
[8]   Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding [J].
Blobel, CP .
INFLAMMATION RESEARCH, 2002, 51 (02) :83-84
[9]   TACE is required for the activation of the EGFR by TGF-α in tumors [J].
Borrell-Pagès, M ;
Rojo, F ;
Albanell, J ;
Baselga, J ;
Arribas, J .
EMBO JOURNAL, 2003, 22 (05) :1114-1124
[10]   Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor [J].
Buxbaum, JD ;
Liu, KN ;
Luo, YX ;
Slack, JL ;
Stocking, KL ;
Peschon, JJ ;
Johnson, RS ;
Castner, BJ ;
Cerretti, DP ;
Black, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27765-27767